Yohimbine+ Rauwolscine
by ALLMAX · capsule · 60 capsules
- On the market (NIH)
- UPC 6 65553 22353 7
- DSLD label 296149
- Serving 1 capsule
- 60 servings
Yohimbine+ Rauwolscine by ALLMAX lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 3 mg of yohimbine hydrochloride and 0.5 mg of rauwolscine. Its current label entered the NIH Dietary Supplement Label Database on September 25, 2023.
What is in Yohimbine+ Rauwolscine?
Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).
| Ingredient | Amount | % DV | Among products listing it |
|---|---|---|---|
| Yohimbine Hydrochloride | 3 mg | 35% of 141 products listing yohimbine give more (median 3 mg). Per day at the most servings: 6 mg. | |
| Rauwolscineas Alpha-Yohimbine | 0.5 mg | 91% of 86 products listing rauwolscine give more (median 1.75 mg). Per day at the most servings: 1 mg. |
Source: NIH ODS Dietary Supplement Label Database, label 296149 (entered September 25, 2023), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.
Is that a lot?
The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:
- 91% of the 86 products that print an amount of rauwolscine list more than its 0.5 mg of rauwolscine (median 1.75 mg).
The NIH database records 1 to 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.
The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.
Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.
Which products have the closest formulas?
1 product lists the very same ingredients; the nearest amounts come first.
- Yohimbine + RauwolscineALLMAX · off the market same ingredients
- RauwolscineGorilla Mind 1 shared, 53% alike
- Alpha YohimbineEA Enhanced 1 shared, 53% alike
- Lipo 6 Black Ultra ConcentrateNutrex Research 2 shared, 48% alike
- Lipo6 Black Ultra ConcentrateNutrex Research 2 shared, 48% alike
- Lipo6 Black Ultra ConcentrateNutrex Research Black Series 2 shared, 48% alike
Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.
What does the label say about taking it?
Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.
- Directions
- Directions: Take 1 capsule daily just prior to exercise. Do not exceed 2 capsules daily.
- Warnings
- Warnings: Do not use if pregnant or nursing. Consult a medical doctor before use if you have been treated for, or diagnose with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. Consult your healthcare professional before use if you are taking antidepressants, MAO inhibitors or any other prescription drug.
- Discontinue use and consult a medical doctor if you experience unusual symptoms. Discontinue use two weeks prior to surgery. Consult a medical doctor before use if you have been treated for, or diagnose with or have a family history of any medical condition, or if you are using any prescription or over-the-counter drug(s), including blood thinners. Do not use this product if you are at risk or are being treated for high blood pressure, heart, kidney, thyroid or psychiatric disease, anxiety, depression, seizure disorder or stroke. Discontinue use and consult your healthcare professional if dizziness, sleeplessness, tremors, nervousness, headache or heart palpitations occur. Improper use of this product will not improve results, is not advised and may cause adverse reactions listed in the warning. Consult a medical doctor before starting any diet or exercise. Do not use if inner seal is broken.
- Keep out of reach of children.
- California Warning: Lead is known to the State of California to cause birth defects or reproductive harm. Consuming this product can expose you to more than 0.0000005 g of lead. For more information go to www.P65Warnings.ca.gov. Prop 65
- Allergen Warning: Produced in a facility that also handles milk, soy, wheat, egg, peanut, tree nuts, fish, crustacean and shellfish products.
- Storage
- Store in a cool, dry place.
Source: label statements in DSLD label 296149.
What else is on the label?
Other ingredients: Bovine Gelatin, Magnesium Stearate, Rice Flour.
Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): cGMP Registered Facility; Quality Guarantee Purity & Potency Tested.
How many labels does Yohimbine+ Rauwolscine have?
One label is on file, entered on September 25, 2023.
- Label 296149 (current) Entered September 25, 2023 · on the market · 60 capsules · UPC 6 65553 22353 7
DSLD also links this label to: Yohimbine + Rauwolscine (image difference, same product).
Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).
Who makes it?
The label names HBS INTERNATIONAL CORP. (distributor), Carson City, NV, 89701. All ALLMAX products.